Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kissel, J. T.
Right arrow Articles by Mendell, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kissel, J. T.
Right arrow Articles by Mendell, J. R.
NEUROLOGY 1985;35:828
© 1985 American Academy of Neurology

Physiologic assessment of phosphoglycerate mutase deficiency

Incremental exercise tests

John T. Kissel, MD, William Beam, PhD, Nereo Bresolin, MD, Greg Gibbons, MD, Salvatore DiMauro, MD and Jerry R. Mendell, MD

Department of Neurology of the Ohio State University College of Medicine and the Department of Exercise Physiology, Ohio State University, Columbus, OH; and the H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Columbia University College of Physicians and Surgeons, New York.

A third case of phosphoglycerate mutase (PGAM) deficiency, a metabolic myopathy involving terminal glycolysis, was identified in a 24-year-old black man with episodic, exercise-induced myoglobinuria since age 13. To better understand the physiologic consequences of PGAM deficiency, incremental exercise testing was performed. Results were compared with those of two patients having myophosphorylase deficiency and five normals. In contrast to the patients with phosphorylase deficiency, the PGAM-deficient patient achieved near-normal levels of maximal exercise and produced a normal peak lactate after exercise. The mechanisms underlying the asymptomatic performance of such strenuous exercise in this case are uncertain, but the data suggest that unidentified factors are operative in precipitating attacks of myoglobinuria in patients with some metabolic myopathies. Despite similar clinical histories, patients with different glycolytic enzyme deficiencies can have striking differences in exercise tolerance.

Address correspondence and reprint requests to Dr. Kissel, 1655 Upham Drive, Columbus, OH 43210.

Dr. Kissel is the recipient of a postdoctoral research fellowship from the Muscular Dystrophy Association

Accepted for publication October 1, 1984




This article has been cited by other articles:


Home page
Arch NeurolHome page
A. Naini, A. Toscano, O. Musumeci, J. Vissing, H. O. Akman, and S. DiMauro
Muscle Phosphoglycerate Mutase Deficiency Revisited
Arch Neurol, March 1, 2009; 66(3): 394 - 398.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Vissing, B. Quistorff, and R. G. Haller
Effect of Fuels on Exercise Capacity in Muscle Phosphoglycerate Mutase Deficiency
Arch Neurol, September 1, 2005; 62(9): 1440 - 1443.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.